Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality
Shubham Misra, Postdoctoral Associate at Yale Department of Neurology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest study, published in PLOS One, identifies the role of CCL2 as a potential biomarker associated with late seizures and epileptiform discharges (SED) and 90-day mortality post SED in ICH patients.”
Title: Characterizing inflammatory biomarkers in post-stroke seizure risk and outcome prognostication
Authors: Ethan Y. Wang, Shubham Misra, Jennifer Yan, Pei Yi Chook, Yuki Kawamura, Rachel Kitagawa, Jennifer A. Kim, Emily J. Gilmore, Adam de Havenon, Adithya Sivaraju, Lawrence J. Hirsch, Guido J. Falcone, Srikant Rangaraju, Lauren H. Sansing, Jessica Magid-Bernstein, Nishant K. Mishra
Read the Full Article on PLOS One
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 2, 2026, 19:13Syed Fahad Hussain: Not Every Low Platelet Count Tells the Same Story
-
Jul 2, 2026, 18:59Indu Thakur: Supporting Blood Donation Through Public Awareness in MSBT
-
Jul 2, 2026, 18:47Vee Townsend: IMHUE Highlights 9 Myths and Facts About Hemophilia B
-
Jul 2, 2026, 17:17Nico Gagelmann: Launching Myths and Facts on Hematology and Cell Therapy
-
Jul 2, 2026, 17:05Haroun Gajraj: Understanding the Technology Behind Spider Vein Treatment
-
Jul 2, 2026, 16:44Ney Carter Borges: Is It Time to Personalize Antiplatelet Therapy?
-
Jul 2, 2026, 16:22Introducing a New Resource for the ITP Community – ITP Support Association
-
Jul 2, 2026, 16:22Shinto Francis Thekkudan: Delegates Visiting our BMT and Hematology Department from Kazhakstan
-
Jul 2, 2026, 16:13William Aird: When Deciding whether an Adult Patient is Anemic, Which Do You Usually Use?